Original Article

SOCIAL SECURITY BENEFITS FOR PNEUMOCONIOSIS AND CYSTIC FIBROSIS IN THE YEAR 2019

How to cite: Nery TCS, Zago SQGM, Hara EKM. Social security benefits for pneumoconiosis and cystic fibrosis in the year 2019. Persp Med Legal Pericias Med. 2021; 6: e210713

https://dx.doi.org/10.47005/210713

Submitted 02/01/2021
Accepted 04/08/2021

Os autores declaram não haver conflito de interesse.

Telma de Cássia dos Santos Nery (1)

http://lattes.cnpq.br/3194960925056294https://orcid.org/0000-0003-3085-5977

                                                                                                                              Sonia Quézia Garcia Marques Zago (2)

http://lattes.cnpq.br/7405335806355833https://orcid.org/0000-0002-0999-2144

Eric Kiyoshi Mochizuki Hara (3)

http://lattes.cnpq.br/8013862968753011https://orcid.org/0000-0002-3776-7753

(1) Divisão de Pneumologia do Instituto do Coração InCor HCFMUSP, São Paulo – SP, Brasil. (main author)

(2) Discente da Universidade Nove de Julho – Campus São Bernardo do Campo, São Paulo – SP Brasil. (data analysis and structure)

(3) Centro de Atenção ao Colaborador (CeAC), HCFMUSP, São Paulo – SP, Brasil. (literature review and hipothesis complementation)

Email: telma.nery@hc.fm.usp.br

ABSTRACT

Some pathologies generate the need for important social support. In Brazil, the federal constitution provides for social coverage and health care for the entire population. Social assistance, often made possible through social security benefits, can be provided by the National Institute of Social Service (INSS). Open data on these benefits with information on expanded data are available. We highlight here two groups of pathologies that have different profiles in Brazil, but which are often the subject of expert evaluation, due to their clinical characteristics and impact on patients’ quality of life: Pneumoconiosis and Cystic Fibrosis. Objectives: to analyze benefits granted by the INSS in 2019 for Pneumoconiosis and Cystic Fibrosis. Methods: Open data were collected, with analysis in Excel® and SPSS, regarding gender, state, age, type of benefits and ICD 10. Results: 215 benefits were granted for Pneumoconiosis in 21 states, 45% were employed and 50% were granted as work-related. 121 benefits were granted for Cystic Fibrosis in the period. 10 states concentrate 83% of the benefits and 43% were granted to children up to 10 years of age and 9% to those over 51 years of age. Conclusions: Information from open social security data in Brazil can contribute to the regional expert analysis of pathologies characterized as incapacitating, in addition to contributing to the understanding of a change in the regional epidemiological profile of diseases, and enriching the structuring, more frequently providing epidemiological data to official bodies and the adoption of public policies.

Keywords: social security, pneumoconiosis, cystic fibrosis.


Bibliographical references